Cost Of Revenue - UMediC Group Bhd (KLSE:UMC) - Alpha Spread
U

UMediC Group Bhd
KLSE:UMC

Watchlist Manager
UMediC Group Bhd
KLSE:UMC
Watchlist
Price: 0.6 MYR -1.64% Market Closed
Market Cap: 224.3m MYR
Have any thoughts about
UMediC Group Bhd?
Write Note

UMediC Group Bhd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

UMediC Group Bhd
Cost of Revenue Peer Comparison

Comparables:
P
PHARMA

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
U
UMediC Group Bhd
KLSE:UMC
Cost of Revenue
-myr26.5m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Pharmaniaga Bhd
KLSE:PHARMA
Cost of Revenue
-myr3.2B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-6%

See Also

What is UMediC Group Bhd's Cost of Revenue?
Cost of Revenue
-26.5m MYR

Based on the financial report for Jul 31, 2023, UMediC Group Bhd's Cost of Revenue amounts to -26.5m MYR.

What is UMediC Group Bhd's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-18%

Over the last year, the Cost of Revenue growth was 17%. The average annual Cost of Revenue growth rates for UMediC Group Bhd have been -18% over the past three years .

Back to Top